Results

• All
• Video
• Audio
• Images

• Most recent
• Filter by category

1–2 of 2 results for KESTREL

• 

  Brolucizumab for the Treatment of Visual Impairment Due to Diabetic Macular Edema: 52-Week Results From the KESTREL and KITE Studies

  David M. Brown, MD

  Annual Meeting Talks

  2021

• 

  Brolucizumab for the treatment of visual impairment due to diabetic macular edema: 52-week results from the KITE and KESTREL studies

  David M. Brown, MD

  Updates from the Field

  2021